Cencora, Inc. (NYSE:COR – Get Free Report) Director Dermot Mark Durcan purchased 500 shares of the business’s stock in a transaction on Friday, May 24th. The shares were acquired at an average cost of $218.58 per share, with a total value of $109,290.00. Following the acquisition, the director now directly owns 21,876 shares in the […]
Cencora, Inc. (NYSE:COR – Get Free Report) EVP Gina Clark sold 27,093 shares of the stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $216.07, for a total value of $5,853,984.51. Following the completion of the sale, the executive vice president now owns 15,158 shares in the […]
PITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) -- Cencora, Inc. recently announced that it suffered from a cybersecurity attack that occurred in February of...
Cencora, Inc. (NYSE:COR – Get Free Report) Director Dermot Mark Durcan purchased 500 shares of the stock in a transaction on Friday, May 24th. The shares were bought at an average price of $218.58 per share, for a total transaction of $109,290.00. Following the acquisition, the director now owns 21,876 shares of the company’s stock, […]
Cencora, Inc. (NYSE:COR – Get Free Report) Director Dermot Mark Durcan bought 500 shares of Cencora stock in a transaction dated Friday, May 24th. The stock was purchased at an average cost of $218.58 per share, for a total transaction of $109,290.00. Following the completion of the acquisition, the director now directly owns 21,876 shares […]
Novartis Pharmaceuticals, Bayer, GlaxoSmithKline, and eight other major pharmaceutical firms have disclosed the compromise of their patients' information following a cyberattack against large U.S. pharmaceutical services provider Cencora, formerly known as AmericsourceBergen, in February, reports BleepingComputer.
On May 23, 2024, Cencora, Inc. filed a notice of data breach with the Attorney General of California after discovering that data provided to the company by Regeneron Pharmaceuticals,...
Cencora (NYSE:COR – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 13.350-13.550 for the period, compared to the consensus estimate of 13.440. The company issued revenue guidance of -. Cencora also updated its FY24 guidance to $13.35-13.55 EPS. Cencora […]
Cencora (NYSE:COR – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 13.350-13.550 for the period, compared to the consensus EPS estimate of 13.440. The company issued revenue guidance of -. Cencora also updated its FY24 guidance to $13.35-13.55 EPS. Analysts Set New Price Targets Several equities […]
Cencora (NYSE:COR – Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $13.35-13.55 for the period, compared to the consensus estimate of $13.45. Cencora also updated its FY 2024 guidance to 13.350-13.550 EPS. Analyst Ratings Changes COR has been the subject […]